Late Detection of Atrial Fibrillation after Stroke: Implications for the Secondary Prevention

被引:2
|
作者
Tanislav, Christian [1 ]
Kostev, Karel [2 ]
机构
[1] Diakonie Hosp Jung Stilling Siegen, Dept Geriatr & Neurol, Wichernstr 40, DE-57074 Siegen, Germany
[2] IQVIA, Epidemiol, Frankfurt, Germany
关键词
Atrial fibrillation; Stroke; Embolic stroke; Oral anticoagulation; Anticoagulants; CRYPTOGENIC STROKE; ISCHEMIC-STROKE; WARFARIN; DABIGATRAN; DISEASE; YOUNG; SCORE;
D O I
10.1159/000503562
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: This study is aimed at investigating the incidence of atrial fibrillation (AF) within 5 years after an acute cerebrovascular event in AF-naive patients and its relevance for secondary prevention. Methods: The current case-control study sample included patients who had received an initial ischemic stroke diagnosis documented in the Disease Analyzer database (IQVIA), which compiles data such as risk factors, drug prescriptions, and diagnoses obtained from 1,262 general practices in Germany. Results: After the selection procedure, the stroke and non-stroke groups each included 22,774 patients. In both groups, the mean age of the population was 68.0 years (SD +/- 12 years), and the proportion of male participants was 51.1%. Within 5 years of follow-up, we calculated a higher probability for detecting AF in stroke patients than in controls (hazard ratio 4.95; 95% CI 1.93-2.09, p < 0.001). In the stroke group, AF was detected in 2,369 individuals (10.4%), whereas AF was only evident in 1,101 patients (4.8%) in the non-stroke group. In 1,741 (73.5%) patients (out of 2,369), oral anticoagulants had been prescribed after the AF diagnosis. In stroke patients, factors like diabetes mellitus and ischemic heart disease were associated with restraint in prescribing oral anticoagulants; age did not influence the decision for or against oral anticoagulants (mean age 72.9 vs. 72.7 years). Conclusion: A recent stroke is a strong preconditioning factor for detecting AF within 5 years after an acute event. The majority of these patients are treated with oral anticoagulants, regardless of their age.
引用
收藏
页码:262 / 269
页数:8
相关论文
共 50 条
  • [41] Stroke prevention in Atrial Fibrillation
    Lip, Gregory Y. H.
    EUROPEAN HEART JOURNAL, 2017, 38 (01) : 4 - 5
  • [42] Stroke prevention in atrial fibrillation
    Freedman, Ben
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    LANCET, 2016, 388 (10046): : 806 - 817
  • [43] Stroke prevention in atrial fibrillation
    Verheugt, FWA
    NETHERLANDS JOURNAL OF MEDICINE, 2006, 64 (02): : 31 - 33
  • [44] Stroke Prevention in Atrial Fibrillation
    Prabhakaran, Anbazhagan
    Michota, Franklin
    CURRENT EMERGENCY AND HOSPITAL MEDICINE REPORTS, 2013, 1 (02): : 98 - 104
  • [45] Stroke prevention in atrial fibrillation
    Mohammed, Ilyas
    Mohmand-Borkowski, Adam
    Burke, James F.
    Kowey, Peter R.
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2012, 13 (02) : 73 - 85
  • [46] Stroke prevention in atrial fibrillation
    Hart R.G.
    Current Cardiology Reports, 2000, 2 (1) : 51 - 55
  • [47] Atrial fibrillation and stroke prevention
    Lewis, Basil S.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (F11) : F1 - F2
  • [48] Stroke Prevention in Atrial Fibrillation
    Gao, Xu
    Passman, Rod
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (11) : 1765 - 1774
  • [49] Atrial fibrillation and stroke prevention
    Lip, Gregory Y. H.
    Lim, Hoong Sem
    LANCET NEUROLOGY, 2007, 6 (11): : 981 - 993
  • [50] Stroke prevention in atrial fibrillation
    Lip, Gregory Y. H.
    Gue, Ying
    Zhang, Juqian
    Chao, Tze-Fan
    Calkins, Hugh
    Potpara, Tatjana
    TRENDS IN CARDIOVASCULAR MEDICINE, 2022, 32 (08) : 501 - 510